An update to the risk stratification of MGUS, SMM, and multiple myeloma

An update to the risk stratification of MGUS, SMM, and multiple myeloma

Evaluating Monoclonal Gammopathy of Undetermiend Significance (MGUS) with Free Light Chain Assays...Подробнее

Evaluating Monoclonal Gammopathy of Undetermiend Significance (MGUS) with Free Light Chain Assays...

Risk stratification of MGUS and SMM: current and future perspectivesПодробнее

Risk stratification of MGUS and SMM: current and future perspectives

Update on Risk Stratification in MGUS and SMM | Doctors Callander and Beksac | IMS 2023Подробнее

Update on Risk Stratification in MGUS and SMM | Doctors Callander and Beksac | IMS 2023

Diagnosis and Risk Stratification of Plasma Cell Disorders (pt 1 of 5 - IMF ASH Satellite)Подробнее

Diagnosis and Risk Stratification of Plasma Cell Disorders (pt 1 of 5 - IMF ASH Satellite)

Prevalence of Smoldering Multiple Myeloma: Results from the iStopMM StudyПодробнее

Prevalence of Smoldering Multiple Myeloma: Results from the iStopMM Study

Updating the NCCN guidelines for the diagnosis and treatment of MGUS and SMMПодробнее

Updating the NCCN guidelines for the diagnosis and treatment of MGUS and SMM